Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients
出版年份 2015 全文链接
标题
Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients
作者
关键词
Breast cancer, Ki-67, Proliferative marker, Prognostic factor, Meta-analysis
出版物
BREAST CANCER RESEARCH AND TREATMENT
Volume 153, Issue 3, Pages 477-491
出版商
Springer Nature
发表日期
2015-09-04
DOI
10.1007/s10549-015-3559-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The Long-term Prognostic Performance of Ki-67 in Primary Operable Breast Cancer and Evaluation of Its Optimal Cutoff Value
- (2016) Uiju Cho et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
- (2015) A. S. Coates et al. ANNALS OF ONCOLOGY
- Use of modified Magee equations and histologic criteria to predict the Oncotype DX recurrence score
- (2015) Bradley M Turner et al. MODERN PATHOLOGY
- An international study to increase concordance in Ki67 scoring
- (2015) Mei-Yin C Polley et al. MODERN PATHOLOGY
- The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer
- (2015) Nikhil G Thaker et al. SpringerPlus
- Benefit from anthracyclines in relation to biological profiles in early breast cancer
- (2014) Andrea Rocca et al. BREAST CANCER RESEARCH AND TREATMENT
- Prognostic Significance of the Ki67 Scoring Categories in Breast Cancer Subgroups
- (2014) Naoki Niikura et al. Clinical Breast Cancer
- Impact of sentinel node tumor burden on outcome of invasive breast cancer patients
- (2014) I. Meattini et al. EJSO
- Prognostic Value of Ki-67 in Breast Cancer Patients with Positive Axillary Lymph Nodes: A Retrospective Cohort Study
- (2014) Feng-yan Li et al. PLoS One
- Progesterone Receptor Status and Ki-67 Index May Predict Early Relapse in Luminal B/HER2 Negative Breast Cancer Patients: A Retrospective Study
- (2014) Yu Zong et al. PLoS One
- High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in Luminal B HER2 negative and node-positive breast cancer
- (2013) Carmen Criscitiello et al. BREAST
- Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry
- (2013) E. C. Inwald et al. BREAST CANCER RESEARCH AND TREATMENT
- The potential utility of geminin as a predictive biomarker in breast cancer
- (2013) Sreekumar Sundara Rajan et al. BREAST CANCER RESEARCH AND TREATMENT
- Recurrence risk in small, node-negative, early breast cancer: a multicenter retrospective analysis
- (2013) T. Gamucci et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- An International Ki67 Reproducibility Study
- (2013) Mei-Yin C. Polley et al. JNCI-Journal of the National Cancer Institute
- Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population
- (2013) Dennis C Sgroi et al. LANCET ONCOLOGY
- Risk factors of recurrence in small-sized, node negative breast cancer in young women: a retrospective study in Chinese population
- (2013) XiaoSan Zhang et al. Science China-Life Sciences
- Combined analysis of vascular invasion, grade, HER2 and Ki67 expression identifies early breast cancer patients with questionable benefit of systemic adjuvant therapy
- (2012) Marit Synnestvedt et al. ACTA ONCOLOGICA
- Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse
- (2012) G. Cancello et al. ANNALS OF ONCOLOGY
- Is [18F] fluorodeoxyglucose uptake by the primary tumor a prognostic factor in breast cancer?
- (2012) Concetta De Cicco et al. BREAST
- Distribution, clinicopathologic features and survival of breast cancer subtypes in Southern China
- (2012) Cong Xue et al. CANCER SCIENCE
- Clinical relevance of Ki67 gene expression analysis using formalin-fixed paraffin-embedded breast cancer specimens
- (2012) Satoko Yamamoto et al. Breast Cancer
- Prognostic Value of Proliferation Markers: Immunohistochemical Ki-67 Expression and Cytometric S-Phase Fraction of Women with Breast Cancer in Libya
- (2012) Eramah Ermiah et al. Journal of Cancer
- MMP-1 expression has an independent prognostic value in breast cancer
- (2011) Pia Boström et al. BMC CANCER
- Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence score
- (2011) S Sahebjam et al. BRITISH JOURNAL OF CANCER
- Adjuvant Sequencing of Tamoxifen and Anastrozole Is Superior to Tamoxifen Alone in Postmenopausal Women with Low Proliferating Breast Cancer
- (2011) Z. Bago-Horvath et al. CLINICAL CANCER RESEARCH
- Prognostic significance of molecular subtype in T1N0M0 breast cancer: Korean experience
- (2011) R.G. Kim et al. EJSO
- Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer
- (2011) Jack Cuzick et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic molecular markers in women aged 35 years or younger with breast cancer: is there a difference from the older patients?
- (2011) C.-H. Lin et al. JOURNAL OF CLINICAL PATHOLOGY
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- A mitotically active, cellular tumor stroma and/or inflammatory cells associated with tumor cells may contribute to intermediate or high Oncotype DX Recurrence Scores in low-grade invasive breast carcinomas
- (2011) Geza Acs et al. MODERN PATHOLOGY
- The invasive lobular carcinoma as a prototype luminal A breast cancer: A retrospective cohort study
- (2010) So-Youn Jung et al. BMC CANCER
- Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less
- (2010) Ji Hyun Kwon et al. BMC CANCER
- Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients
- (2010) Yasuto Naoi et al. BREAST CANCER RESEARCH AND TREATMENT
- Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer
- (2010) So-Youn Jung et al. BREAST CANCER RESEARCH AND TREATMENT
- Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival
- (2010) Jung Ah Lee et al. BREAST CANCER RESEARCH AND TREATMENT
- BCIRG 001 Molecular Analysis: Prognostic Factors in Node-Positive Breast Cancer Patients Receiving Adjuvant Chemotherapy
- (2010) C. Dumontet et al. CLINICAL CANCER RESEARCH
- Ki-67 as a prognostic marker according to breast cancer subtype and a predictor of recurrence time in primary breast cancer
- (2010) REIKI NISHIMURA et al. Experimental and Therapeutic Medicine
- Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patients
- (2009) Folkward G. Wiesner et al. BREAST
- Validation of UBE2C protein as a prognostic marker in node-positive breast cancer
- (2009) D Loussouarn et al. BRITISH JOURNAL OF CANCER
- Ki67 Expression and Docetaxel Efficacy in Patients With Estrogen Receptor–Positive Breast Cancer
- (2009) Frédérique Penault-Llorca et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- (2009) Alessandro Liberati et al. PLOS MEDICINE
- Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial
- (2008) O. Gluz et al. ANNALS OF ONCOLOGY
- Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature
- (2008) Andrew Tutt et al. BMC CANCER
- Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patients
- (2008) R. Stuart-Harris et al. BREAST
- Altered Cytoplasmic-to-Nuclear Ratio of Survivin Is a Prognostic Indicator in Breast Cancer
- (2008) D. J. Brennan et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now